125 results on '"Casà A"'
Search Results
2. Indolent EBV-positive T-cell lymphoma of the gastrointestinal tract with metachronous lesions involved by different neoplastic clones
3. Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1)
4. Role of radiomics in predicting lymph node metastasis in gastric cancer: a systematic review
5. KIT 1 (Keep in Touch) Project—Televisits for Cancer Patients during Italian Lockdown for COVID-19 Pandemic: The Real-World Experience of Establishing a Telemedicine System
6. Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologics
7. Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review
8. Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
9. Integration of art and technology in personalized radiation oncology care: Experiences, evidence, and perspectives
10. Switching from SB2 to PF-06438179/GP1111 and back in inflammatory bowel disease: “The Superswitchers”
11. Come cambia la percezione della professione medica di fronte alla richiesta di morte
12. Art and digital technologies to support resilience during the oncological journey: The Art4ART project
13. Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn, MITO and MaNGO groups
14. Assessment of Sexual Dysfunction in Cervical Cancer Patients after Different Treatment Modality: A Systematic Review
15. The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's disease
16. Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets
17. ORIFICE (Interventional Radiotherapy for Face Aesthetic Preservation) Study: Results of Interdisciplinary Assessment of Interstitial Interventional Radiotherapy (Brachytherapy) for Periorificial Face Cancer
18. PO-1488 Brachytherapy plan reproducibility in gynecological cancer patients
19. Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
20. OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE
21. Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort
22. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19
23. Immunosuppressive treatment and radiotherapy in kidney transplant patients: A systematic review
24. Effectiveness and safety of an on-demand ferric carboxymaltose infusion strategy in patients with inflammatory bowel disease: a real world experience
25. EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates
26. Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation
27. Contact skin radiotherapy (brachytherapy) for the treatment of non‐melanoma skin cancers during COVID ‐19 pandemic
28. P345 The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn’s Disease
29. P347 Sarcopenia is a poor prognostic factor for endoscopic outcomes in patients with Crohn’s disease
30. The impact of radiomics in diagnosis and staging of pancreatic cancer
31. Radiological and clinical findings in uveal melanoma treated by plaque interventional radiotherapy (brachytherapy): Visual atlas and literature review on response assessment
32. The Radiotherapy Role in the Multidisciplinary Management of Locally Advanced Vulvar Cancer: A Multidisciplinary VulCan Team Review
33. 1112 A national retrospective study on efficacy of exclusive (chemo)radiotherapy for vulvar cancer
34. 1103 A national retrospective study on efficacy of adjuvant (chemo)radiotherapy for vulvar cancer
35. Alginate Nanohydrogels as a Biocompatible Platform for the Controlled Release of a Hydrophilic Herbicide
36. Radiation therapy for prostate cancer: What’s the best in 2021
37. OC.09.8 BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS TREATED WITH BIOLOGICS: A NEW PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
38. AF.57 SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
39. AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE
40. The “PC-WIRED” study: atient entred volution of ebsites of talian adiotherapy epartments
41. PO-1292 Results of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer
42. PH-0445 Preliminary results of the Italian Retrospective Study on adjuvant radiotherapy for vulvar cancer
43. OC-0297 Preliminary results of the Italian Retrospective Study on exclusive radiotherapy for vulvar cancer
44. PO-1481 The “PC-WIRED” study: Patient Centred Evolution of Websites of Italian Radiotherapy Departments
45. PO-1721 Use of a bolus for skin cancer interventional radiotherapy in absence of model-based algorithms.
46. PO-1459 QUALIFIER:multiprofessionality quality assurance program for endovaginal interventional radiotherapy
47. Blood-based prognostic biomarkers in Crohn’s Disease patients on biologics: a promising tool to predict endoscopic outcomes
48. A radiotherapy staff experience of gratitude during COVID-19 pandemic
49. P439 Effectiveness of Ustekinumab on Crohn’s disease associated spondyloartropathy: real-world data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
50. Su453 BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN'S DISEASE PATIENTS TREATED WITH BIOLOGICS: A NEW PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.